InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Lindborg Stacy. Director active across 2 companies, notably Brainstorm Cell Therapeutics INC.. In total, 13 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €41k. Activity tracked since 7 December 2022. The latest transaction was filed on 14 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Lindborg Stacy is a declarant associated with Imunon, Inc. and Brainstorm Cell Therapeutics INC., with the listed roles of President and CEO at Imunon, Inc. and Director at Brainstorm Cell Therapeutics INC. The total number of filings is 12, and among the sampled recent filings from 2023-01-04 to 2026-08-04, buys total 41142 EUR and sells total 0 EUR, with the modal transaction nature listed as Attribution.